title: Beta-adrenoceptor blockade potentiates exercise-induced release of atrial natriuretic peptide.
abstract: The effect of a non selective and a cardio-selective beta-blocker on basal and exercise-stimulated plasma atrial natriuretic peptide concentrations in healthy volunteers has been studied. Nine healthy volunteers received single oral doses of 5 mg tertatolol, 100 mg atenolol or placebo, at one week intervals, in a double blind cross over trial. At rest plasma atrial natriuretic peptide, aldosterone, antidiuretic hormone and cyclic GMP concentrations and plasma renin activity were not modified by the treatments. During exercise plasma atrial natriuretic peptide concentrations were significantly increased by each treatment, the increment being significantly greater on beta-blockers than on placebo. The rise in atrial natriuretic peptide was 72% after placebo (from 24 to 42 pg/ml), 184% after atenolol (from 30 to 86 pg/ml), and 183% after tertatolol (from 34 to 95 pg/ml), respectively. Thus, the study has shown that in healthy subjects the plasma natriuretic peptide concentration is increased by exercise and that the increase is considerably and equally potentiated by selective and non selective beta-adrenoceptor blockade. The effect may be mainly due to a reduction in ventricular contractility with an increase in atrial pressure. The beta-blockers did not influence the resting plasma atrial natriuretic peptide levels, which suggests that in healthy subjects basal atrial natriuretic peptide secretion is not controlled via beta-receptors.
authors.affiliation: Department of Nephrology, Hôpital Pitie-Salpetriere, Paris, France.
authors.forename: G
authors.initials: G
authors.lastname: Deray
authors.forename: I
authors.initials: I
authors.lastname: Berlin
authors.forename: G
authors.initials: G
authors.lastname: Maistre
authors.forename: F
authors.initials: F
authors.lastname: Martinez
authors.forename: S
authors.initials: S
authors.lastname: Legrand
authors.forename: A
authors.initials: A
authors.lastname: Carayon
authors.forename: A
authors.initials: A
authors.lastname: Prost
authors.forename: A
authors.initials: A
authors.lastname: Puech
authors.forename: F
authors.initials: F
authors.lastname: Masson
authors.forename: J C
authors.initials: JC
authors.lastname: Legrand
mesh_terms: D000319:Adrenergic beta-Antagonists / Q000494:pharmacology*; D000328:Adult; D001262:Atenolol / Q000494:pharmacology*; D009320:Atrial Natriuretic Factor / Q000097:blood*; D004311:Double-Blind Method; D015444:Exercise / Q000502:physiology*; D006801:Humans; D008297:Male; D011412:Propanolamines / Q000494:pharmacology*; D013876:Thiophenes
chemical_list: D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; D013876:Thiophenes; D001262:Atenolol; D009320:Atrial Natriuretic Factor; C005632:tertatolol